Buy Crypto Markets Spot OIL FuturesOIL Earn Event Center

Galmed Pharmaceuticals Ltd. (GLMD)

NASDAQ

$0.87

$+0.23

(+37.70%)

Galmed Pharmaceuticals Ltd. (GLMD) Live Price Chart

Page last updated: 2026-04-09 15:04:00

Key Market Data

Market Cap	$5.71M
Open	$1.16
High	$4,870.80
Low	$0.41
Previous Close	$0.62
Price Change	$+0.23
Percentage Change	+37.70%
Volume	154M

Galmed Pharmaceuticals Ltd. (GLMD) Stock Price Today

Galmed Pharmaceuticals Ltd. (GLMD) is currently trading at $0.87 as of 2026-04-09 15:04:00, reflecting a +37.70% move ($+0.23) from the previous close.

In the short term, the stock has returned +37.34% over the past four weeks. Over the last 12 months, Galmed Pharmaceuticals Ltd. has recorded a -38.87% price change, indicating a weak performance relative to the broader market.

Galmed Pharmaceuticals Ltd. (GLMD) 7-Day Stock Price Changes

Over the past seven days, Galmed Pharmaceuticals Ltd. has traded within a short-term range shaped by market sentiment in the sector. During this period, the stock moved from its previous closing price of $0.52 to the latest recorded price of $0.87, reflecting an intraday change of +37.70%. Daily movements highlight shifts in trading volume (153,836,261), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, GLMD has delivered a +37.34% return over the past month and a -38.87% change in the last 12 months, indicating a weak trend relative to its broader sector peers.

How to Buy Galmed Pharmaceuticals Ltd. (GLMD)

You can buy and trade GLMD on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for GLMD and Execute Your Trade

Open the trading page, enter GLMD in the search bar, select the amount of GLMD you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Galmed Pharmaceuticals Ltd. (GLMD)?

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

Galmed Pharmaceuticals Ltd. Information

Industry	--
Employees	6
Sector	--
Company Website	https://www.galmedpharma.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Galmed Pharmaceuticals Ltd.?

The latest trading price for Galmed Pharmaceuticals Ltd. (Common Stock) is $ 0.87, compared with a previous closing price of $ 0.62. That means the stock has moved +37.70% so far today. Intraday price updates and recent trading activity for GLMD can be tracked on the live chart and quote section on this page.

2.Is Galmed Pharmaceuticals Ltd. stock going up or down?

Looking at recent performances, GLMD has returned +37.34% over the past month, -40.95% over the last six months and -38.87% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe weak price momentum for Galmed Pharmaceuticals Ltd. stock, but keep in mind that past returns do not guarantee future results.

3.Where does GLMD currently sit relative to its 52-week high and low?

In the most recent 52-week period, Galmed Pharmaceuticals Ltd. has traded between a low of $ 0.41 and a high of $ 2.68. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether GLMD is currently nearer the top or the bottom of its one-year trading band.

4.How is Galmed Pharmaceuticals Ltd. classified by sector and industry?

Galmed Pharmaceuticals Ltd. is classified in the -- sector. In practice, this means Galmed Pharmaceuticals Ltd. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing GLMD’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the -- sector could influence Galmed Pharmaceuticals Ltd.’s performance.

5.Where is Galmed Pharmaceuticals Ltd. listed and how large is it by market value?

Galmed Pharmaceuticals Ltd. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 5.71M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Galmed Pharmaceuticals Ltd.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does GLMD's EPS tell investors about its profitability?

Trailing-twelve-month EPS of -- summarises how much profit Galmed Pharmaceuticals Ltd. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Galmed Pharmaceuticals Ltd.'s financial performance over time?

To follow Galmed Pharmaceuticals Ltd.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how GLMD is performing and how the market is responding.

8.When is Galmed Pharmaceuticals Ltd. expected to report earnings?

Galmed Pharmaceuticals Ltd.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for GLMD, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Galmed Pharmaceuticals Ltd.'s earnings reports?

Galmed Pharmaceuticals Ltd.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether GLMD is meeting, beating or missing expectations.

10.How can I stay informed about Galmed Pharmaceuticals Ltd.'s results and guidance?

You can stay up to date on Galmed Pharmaceuticals Ltd. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for GLMD on this page helps you see how new information is being reflected in the stock.

11.Does Galmed Pharmaceuticals Ltd. pay a regular cash dividend to its shareholders?

Galmed Pharmaceuticals Ltd. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of -- at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor GLMD's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for GLMD?

Based on the latest earnings data, GLMD has a dividend yield of -- and a dividend payout ratio of --. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Galmed Pharmaceuticals Ltd. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Galmed Pharmaceuticals Ltd. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Galmed Pharmaceuticals Ltd.?

Galmed Pharmaceuticals Ltd. is a publicly traded company in the -- industry within the -- sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is GLMD valued in terms of P/E ratio and EPS?

Galmed Pharmaceuticals Ltd. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of --. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Galmed Pharmaceuticals Ltd.'s earnings. Comparing GLMD's P/E and EPS to those of other -- companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Galmed Pharmaceuticals Ltd.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Bank of Hawaii Corp.

BOH

Brandywine Realty Trust

BDN

Peabody Energy Corporation

BTU

Brady Corporation

BRC

Aptiv PLC

APTV

Top Gainers

Browse today's leading gainers in the US stock market

DKI

Galmed Pharmaceuticals Ltd.

GLMD

GameSquare Holdings, Inc.

GAME

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

GLMD-to-USD Calculator

Amount

GLMD

USD

1 GLMD = 0.868 USD